- Home
- IMRX vs NRO Comparison
IMRX vs NRO Comparison
Compare IMRX & NRO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMRX
- NRO
- Stock Information
- Founded
- IMRX 2008
- NRO 2003
- Country
- IMRX United States
- NRO United States
- Employees
- IMRX N/A
- NRO N/A
- Industry
- IMRX Biotechnology: Pharmaceutical Preparations
- NRO Finance/Investors Services
- Sector
- IMRX Health Care
- NRO Finance
- Exchange
- IMRX Nasdaq
- NRO Nasdaq
- Market Cap
- IMRX 145.7M
- NRO 156.7M
- IPO Year
- IMRX 2021
- NRO N/A
- Fundamental
- Price
- IMRX $3.52
- NRO $3.24
- Analyst Decision
- IMRX Strong Buy
- NRO
- Analyst Count
- IMRX 4
- NRO 0
- Target Price
- IMRX $13.25
- NRO N/A
- AVG Volume (30 Days)
- IMRX 486.1K
- NRO 239.4K
- Earning Date
- IMRX 08-19-2025
- NRO 01-01-0001
- Dividend Yield
- IMRX N/A
- NRO 11.41%
- EPS Growth
- IMRX N/A
- NRO N/A
- EPS
- IMRX N/A
- NRO N/A
- Revenue
- IMRX N/A
- NRO N/A
- Revenue This Year
- IMRX N/A
- NRO N/A
- Revenue Next Year
- IMRX N/A
- NRO N/A
- P/E Ratio
- IMRX N/A
- NRO N/A
- Revenue Growth
- IMRX N/A
- NRO N/A
- 52 Week Low
- IMRX $1.00
- NRO $2.51
- 52 Week High
- IMRX $4.69
- NRO $3.45
- Technical
- Relative Strength Index (RSI)
- IMRX 47.82
- NRO 51.89
- Support Level
- IMRX $3.25
- NRO $3.20
- Resistance Level
- IMRX $4.69
- NRO $3.26
- Average True Range (ATR)
- IMRX 0.28
- NRO 0.03
- MACD
- IMRX -0.13
- NRO 0.00
- Stochastic Oscillator
- IMRX 18.76
- NRO 64.29
About IMRX Immuneering Corporation
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.
About NRO Neuberger Berman Real Estate Securities Income Fund Inc.
NEUBERGER BERMAN REAL ESTATE SECURITIES INCOME FUND INC is a closed-end management investment company that invests mainly in securities issued by real estate companies, including real estate investment trusts (REITs). Its primary objective is to gain high current income with capital appreciation being the second. Under normal market conditions, the Fund invests at least 90% of its total assets in income-producing common equity securities, preferred securities, convertible securities and non-convertible debt securities issued by real estate companies, including real estate investment trusts ("REITs").